IT1240683B - Composizione farmaceutica contenente egf - Google Patents

Composizione farmaceutica contenente egf

Info

Publication number
IT1240683B
IT1240683B IT20144A IT2014490A IT1240683B IT 1240683 B IT1240683 B IT 1240683B IT 20144 A IT20144 A IT 20144A IT 2014490 A IT2014490 A IT 2014490A IT 1240683 B IT1240683 B IT 1240683B
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
composition containing
containing egf
egf
treatment
Prior art date
Application number
IT20144A
Other languages
English (en)
Other versions
IT9020144A1 (it
IT9020144A0 (it
Inventor
Angelo Carenzi
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to IT20144A priority Critical patent/IT1240683B/it
Publication of IT9020144A0 publication Critical patent/IT9020144A0/it
Priority to AT91106438T priority patent/ATE167060T1/de
Priority to ES91106438T priority patent/ES2118726T3/es
Priority to DE69129563T priority patent/DE69129563T2/de
Priority to EP91106438A priority patent/EP0454026B1/en
Priority to US07/690,670 priority patent/US5200396A/en
Publication of IT9020144A1 publication Critical patent/IT9020144A1/it
Application granted granted Critical
Publication of IT1240683B publication Critical patent/IT1240683B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT20144A 1990-04-26 1990-04-26 Composizione farmaceutica contenente egf IT1240683B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT20144A IT1240683B (it) 1990-04-26 1990-04-26 Composizione farmaceutica contenente egf
AT91106438T ATE167060T1 (de) 1990-04-26 1991-04-22 Epidermis-wachstumsfaktor als arzneimittel zur wiederherstellung der neuronen der substantia nigra in der behandlung nervenzerstörender störungen
ES91106438T ES2118726T3 (es) 1990-04-26 1991-04-22 Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos.
DE69129563T DE69129563T2 (de) 1990-04-26 1991-04-22 Epidermis-Wachstumsfaktor als Arzneimittel zur Wiederherstellung der Neuronen der Substantia nigra in der Behandlung nervenzerstörender Störungen
EP91106438A EP0454026B1 (en) 1990-04-26 1991-04-22 Epidermal growth factor as a medicament for the restoration of neurons of the substantia nigra in the treatment of neurodegenerative disorders
US07/690,670 US5200396A (en) 1990-04-26 1991-04-24 Method of treating neurodegenerative disorders using epidermal growth factor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20144A IT1240683B (it) 1990-04-26 1990-04-26 Composizione farmaceutica contenente egf

Publications (3)

Publication Number Publication Date
IT9020144A0 IT9020144A0 (it) 1990-04-26
IT9020144A1 IT9020144A1 (it) 1991-10-26
IT1240683B true IT1240683B (it) 1993-12-17

Family

ID=11164158

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20144A IT1240683B (it) 1990-04-26 1990-04-26 Composizione farmaceutica contenente egf

Country Status (6)

Country Link
US (1) US5200396A (it)
EP (1) EP0454026B1 (it)
AT (1) ATE167060T1 (it)
DE (1) DE69129563T2 (it)
ES (1) ES2118726T3 (it)
IT (1) IT1240683B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4237047A1 (en) * 1991-11-04 1993-05-06 I N R O Handels-Gmbh, 8750 Aschaffenburg, De Drug contg. polypeptide homologous to nerve growth factor and slow virus sequence - for treating amyotrophic lateral sclerosis, spinal muscle atrophy or Parkinson's disease
FR2684301B1 (fr) * 1991-12-02 1995-03-24 Synthelabo Composition pharmaceutique contenant de l'egf pour le traitement des pathologies bronchopulmonaires.
WO1994009371A1 (en) * 1992-10-09 1994-04-28 Massachusetts Institute Of Technology Antemortem diagnostic test for alzheimer's disease
ES2189807T3 (es) * 1993-11-09 2003-07-16 Neurospheres Holdings Ltd Modificacion y manipulacion in situ de celulas madre del sistema nervioso central.
EP0743066A3 (en) * 1995-05-16 1998-09-30 Mitsui Pharmaceuticals, Inc. Wound-healing agent
AU2002322264A1 (en) * 2001-06-14 2003-01-02 Bristol-Myers Squibb Company Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue
KR100711145B1 (ko) * 2002-07-03 2007-04-24 (주)넥스젠 상피세포재생인자 및 인간 혈청 알부민을 포함하는 융합폴리펩타이드
ES2304818B1 (es) * 2005-05-23 2009-10-26 Universidad Del Pais Vasco Metodos para el diagnostico y pronostico de las enfermedades desmielinizantes y para el desarrollo de medicamentos contra las enfermedades desmielinizantes.
CN101897953B (zh) * 2009-05-27 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 无创性高穿透性表皮生长因子及其应用
WO2013166487A1 (en) 2012-05-04 2013-11-07 Yale University Highly penetrative nanocarriers for treatment of cns disease
CN103204920A (zh) * 2013-04-28 2013-07-17 中国人民解放军军事医学科学院毒物药物研究所 一种新型表皮生长因子及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE38892B1 (en) * 1973-03-28 1978-06-21 Ici Ltd Pharmaceutical compositions
ATE73345T1 (de) * 1984-10-19 1992-03-15 Chiron Corp Anregung zur heilung einer wunde mittels menschlichen hautwachstumsfaktors hergestellt durch rekombinant-dns.
NZ235556A (en) * 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf
US4861757A (en) * 1986-11-14 1989-08-29 Institute Of Molecular Biology Wound healing and bone regeneration using PDGF and IGF-I
US5057494A (en) * 1988-08-03 1991-10-15 Ethicon, Inc. Method for preventing tissue damage after an ischemic episode
US5036046A (en) * 1988-10-12 1991-07-30 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
WO1990011781A1 (en) * 1989-04-04 1990-10-18 Alcon Laboratories, Inc. The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
JP3187410B2 (ja) * 1989-08-10 2001-07-11 住友製薬株式会社 脳内投与用徐放性製剤

Also Published As

Publication number Publication date
IT9020144A1 (it) 1991-10-26
ES2118726T3 (es) 1998-10-01
ATE167060T1 (de) 1998-06-15
EP0454026B1 (en) 1998-06-10
EP0454026A1 (en) 1991-10-30
US5200396A (en) 1993-04-06
IT9020144A0 (it) 1990-04-26
DE69129563T2 (de) 1999-01-07
DE69129563D1 (de) 1998-07-16

Similar Documents

Publication Publication Date Title
DE69427704D1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
ZA885192B (en) Pharmaceutical preparations
DE69232323D1 (de) Verwendung von Adenosinantagonisten zur Vorbeugung und Behandlung von Pankreatitis und Ulcera
LV12284A (lv) No kudras izdaliti bioaktivi produkti un tos saturosas farmaceitiskas un kosmetiskas kompozicijas
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
FI892454A0 (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
ATE199167T1 (de) Nichtglykosyliertes fgf-4 und dieses enthaltende präparate
ATA186692A (de) Pharmazeutische zusammensetzung
DK0443224T3 (da) Anvendelse af thrombospondin til fremskyndelse af sårheling
IT1240683B (it) Composizione farmaceutica contenente egf
SE8404065D0 (sv) Novel biologically active compounds
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
GR1001511B (el) Στεροειδείς συν?έσεις.
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
SE8600658D0 (sv) Novel composition of matter
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ATE345809T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
DE69327693D1 (de) Interferon-Alpha/Beta bindendes Protein, seine Herstellung und seine enthaltende pharmazeutische Zusammensetzungen
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
EP0618812A4 (en) USE OF PROTEASE NEXIN-I AS ANTI-INFLAMMATORY.
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
ES2126580T3 (es) Proteina condromodulina-ii.
ATE131382T1 (de) Mittel zur topischen behandlung von verbrennungen

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970311